Immune therapy | Target | Stage | Cancer type | Ref. |
---|---|---|---|---|
Ipilimumab | CTLA-4 | Clinical use | Advanced melanoma | 107 |
Nivolumab | PD-1 | Clinical use | Melanoma Renal cancer NSLC | 108 109 110 |
Pembrolizumab | PD-1 | Clinical use | Melanoma | 111 |
Atezolizumab | PD-L1 | Clinical use | NSLC Clear renal cancer bladder cancer | 112 113 |
Sipileucel | Peripheral blood mononuclear cells | Clinical use | Prostate cancer | 114 |